Nicotine- and methamphetamine-induced dopamine release evaluated with in-vivo binding of radiolabelled raclopride to dopamine D2 receptors: Comparison with in-vivo microdialysis data

International Journal of Neuropsychopharmacology

Volumn 12, Issue 6, 2009, Pages 833-841

  Kim, Sang Eun ^a   Han, Seung Moo ^b  

^a Seoul National University Bundang Hospital   (South Korea)

^b Kyung Hee University   (South Korea)

Author keywords

Dopamine release; In vivo microdialysis; Methamphetamine; Nicotine; Radiolabelled raclopride binding

Indexed keywords

DOPAMINE; DOPAMINE 2 RECEPTOR; METHAMPHETAMINE; NICOTINE; RACLOPRIDE; DOPAMINE RECEPTOR STIMULATING AGENT; NICOTINIC AGENT; TRITIUM;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN; CONTROLLED STUDY; CORPUS STRIATUM; CORRELATION ANALYSIS; DOPAMINE RELEASE; DOSE RESPONSE; IN VIVO STUDY; ISOTOPE LABELING; LINEAR REGRESSION ANALYSIS; MALE; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; ANALYSIS OF VARIANCE; ANIMAL; DRUG EFFECT; DRUG INTERACTION; METABOLISM; METHODOLOGY; PROTEIN BINDING; SCINTISCANNING; SPRAGUE DAWLEY RAT;

ANALYSIS OF VARIANCE; ANIMALS; BRAIN; DOPAMINE; DOPAMINE AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; MALE; METHAMPHETAMINE; MICRODIALYSIS; NICOTINE; NICOTINIC AGONISTS; PROTEIN BINDING; RACLOPRIDE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D2; TRITIUM;

EID: 68849084122     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145708009826     Document Type: Article

References (39)

1. Abi-Dargham A, Gil R, Krystal J, Baldwin RM, Seibyl JP, Bowers M, van Dyck CH, Charney DS, Innis RB, Laruelle M (1998). Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort. American Journal of Psychiatry 155, 761-767.
2. 2 receptors by dopamine in schizophrenia. Proceedings of the National Academy of Sciences USA 97, 8104-8109.
3. Booij J, Korn P, Linszen DH, van Royen EA (1997). Assessment of endogenous dopamine release by methylphenidate challenge using iodine-123 iodobenzamide single-photon emission tomography. European Journal of Nuclear Medicine 24, 674-677.
4. Breier A, Su TP, Saunders R, Carson RE, Kolachana BS, de Bartolomeis A, Weinberger DR, Weisenfeld N, Malhotra AK, Eckelman WC, Pickar D (1997). Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method. Proceedings of the National Academy of Sciences USA 94, 2569-2574.
5. 11C]raclopride binding with continuous infusion. Journal of Cerebral Blood Flow and Metabolism 17, 437-447.
6. 11C-raclopride is altered by drugs that modify synaptic dopamine levels. Synapse 13, 350-356.
7. Di Chiara G, Imperato A (1988). Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proceedings of the National Academy of Sciences USA 85, 5274-5278.
8. Grace AA (1991). Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia. Neuroscience 41, 1-24.
9. Grace AA (1993). Cortical regulation of subcortical systems and its possible relevance to schizophrenia. Journal of Neural Transmission 91, 111-134.
10. Grace AA (2001) Psychostimulant actions on dopamine and limbic system function: relevance to the pathophysiology and treatment of ADHD. In: Solanto MV,
11. 3H]dopamine release from mouse striatal synaptosomes. Journal of Neurochemistry 62, 1390-1398.
12. Grenhoff J, Aston-Jones G, Svensson TH (1986). Nicotinic effects on the firing pattern of midbrain dopamine neurons. Acta Physiologica Scandinavica 128, 351-358.
13. Hartvig P, Torstenson R, Tedroff J, Watanabe Y, Fasth KJ, Bjurling P, Langstrom B (1997). Amphetamine effects on dopamine release and synthesis rate studied in the Rhesus monkey brain by positron emission tomography. Journal of Neural Transmission 104, 329-339.
14. Imperato A, Mulas A, Di Chiara G (1986). Nicotine preferentially stimulates dopamine release in the limbic system of freely moving rats. European Journal of Pharmacology 132, 337-338.
15. Inoue O, Tsukada H, Yonezawa H, Suhara T, Langstrom B (1991). Reserpine-induced reduction of in vivo binding of SCH 23390 and N-methylspiperone and its reversal by D-amphetamine. European Journal of Pharmacology 197, 143-149.
16. 11C]raclopride continuous infusion. Journal of Nuclear Medicine 45 (Suppl.), 128P.
17. Kim SE, Shim I, Oh SJ, Kim SH, Choe YS, Choi Y, Kim BT (1998). Nicotine-induced dopamine release evaluated with in vivo H-3 raclopride binding studies: comparison with in vivo microdialysis data. Journal of Nuclear Medicine 39 (Suppl.), 54P.
18. Koepp MJ, Gunn RN, Lawrence AD, Cunningham VJ, Dagher A, Jones T, Brooks DJ, Bench CJ, Grasby PM (1998). Evidence for striatal dopamine release during a video game. Nature 393, 266-268.
19. Krauss M, Korr D, Herrmann A, Hucho F (2000). Binding properties of agonists and antagonists to distinct allosteric states of the nicotinic acetylcholine receptor are incompatible with a concerted model. Journal of Biological Chemistry 275, 30196-30201.
20. Kuczenski R, Segal D (1989). Concomitant characterization of behavioral and striatal neurotransmitter response to amphetamine using in vivo microdialysis. Journal of Neuroscience 9, 2051-2065.
21. Laruelle M (2000). Imaging synaptic neurotransmission with in vivo binding competition techniques: a critical review. Journal of Cerebral Blood Flow and Metabolism 20, 423-451.
22. Laruelle M, Abi-Dargham A, van Dyck CH, Rosenblatt W, Zea-Ponce Y, Zoghbi SS, Baldwin RM, Charney DS, Hoffer PB, Kung HF, Innis RB (1995). SPECT imaging of striatal dopamine release after amphetamine challenge. Journal of Nuclear Medicine 36, 1182-1190.
23. Laruelle M, Iyer RN, Al-Tikriti MS, Zea-Ponce Y, Malison R, Zoghbi SS, Baldwin RM, Kung HF, Charney DS, Hoffer PB, Innis RB, Bradberry CW (1997). Microdialysis and SPECT measurements of amphetamine-induced dopamine release in nonhuman primates. Synapse 25, 1-14.
24. 11C]raclopride PET. Neuropsychopharmacology 29, 259-268.
25. Mereu G, Yoon KW, Boi V, Gessa GL, Naes L, Westfall TC (1987). Preferential stimulation of ventral tegmental area dopaminergic neurons by nicotine. European Journal of Pharmacology 141, 395-399.
26. Middleton LS, Cass WA, Dwoskin LP (2004). Nicotinic receptor modulation of dopamine transporter function in rat striatum and medial prefrontal cortex. Journal of Pharmacology and Experimental Therapeutics 308, 367-377.
27. Murase S, Grenhoff J, Chouvet G, Gonon FG, Svensson TH (1993). Prefrontal cortex regulates burst firing and transmitter release in rat mesolimbic dopamine neurons studied in vivo. Neuroscience Letters 157, 53-56.
28. 11C]raclopride in baboons. Journal of Pharmacology and Experimental Therapeutics 315, 80-90.
29. Paxinos G, Watson C (1986). The Rat Brain in Stereotaxic Coordinates, 2nd edn. New York: Academic Press. Ross SB, Jackson DM (1989). Kinetic properties of the in vivo accumulation of the dopamine D-2 receptor antagonist raclopride in the mouse brain in vivo. Naunyn-Schmiedeberg's Archives of Pharmacology 340, 6-12.
30. 11C]raclopride at dopamine receptors in human subjects. American Journal of Psychiatry 154, 1209-1213.
31. Schultz W (2000). Multiple reward signals in the brain. Nature Reviews Neuroscience 1, 199-207.
32. 11C-raclopride in normal human subjects. Neuropsychopharmacology 18, 18-25.
33. 11C]raclopride binding in unanesthetized monkeys. Synapse 45, 207-212.
34. 11C]raclopride?: PET studies combined with microdialysis in conscious monkeys. Brain Research 841, 160-169.
35. Volkow ND, Fowler JS, Gatley SJ, Dewey SL, Wang GJ, Logan Ding YS, Franceschi D, Gifford A, Morgan A, Pappas N, King P (1999). Comparable changes in synaptic dopamine induced by methylphenidate and by cocaine in the baboon brain. Synapse 31, 59-66.
36. Volkow ND, Wang GJ, Fowler JS, Logan J, Gatley SJ, Hitzemann R, Chen AD, Dewey SL, Pappas N (1997). Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects. Nature 386, 830-833.
37. 11C]raclopride in the human brain. Synapse 16, 255-262.
38. 11C]raclopride in the human brain in response to methylphenidate. Journal of Nuclear Medicine 40, 1285-1291.
39. 3H]raclopride binding in the rat brain. Synapse 9, 188-194.